INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $82.5M invested in Infinity Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Holders
97
Holding in Top 10
–
Calls
$2.88M
Puts
$655K
Top Buyers
| 1 | +$2.15M | |
| 2 | +$1.73M | |
| 3 | +$1.54M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.31M |
| 5 |
Renaissance Technologies
New York
|
+$713K |
Top Sellers
| 1 | -$4.97M | |
| 2 | -$4.57M | |
| 3 | -$4.1M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.89M |
| 5 |
Two Sigma Investments
New York
|
-$2.18M |